Furthermore, our analysis reveals a wide range in the breadth of tumor neoantigens restricted to specific HLA alleles, ranging from 3.5% of neoantigens arising from driver genes bound by HLA-B*37:01 to 18.6% of neoantigens bound by HLA-B*83:01 (Figure 2C). Here, HLA-B is linked to neoplasm.